| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 401 |
| 1 | OMALIZUMAB | 394 |
| 2 | ASPIRIN | 326 |
| 3 | ASPIRIN 325 MG | 324 |
| 4 | ASPIRIN 81 MG | 324 |
| 5 | MONTELUKAST SODIUM | 315 |
| 6 | ERGOCALCIFEROL | 313 |
| 7 | RITUXIMAB | 306 |
| 8 | CLONAZEPAM | 305 |
| 9 | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | 274 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLOPHEDIANOL HYDROCHLORIDE, DEXCHLORPHENIRAMINE MALEATE, AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.1250 |
| 1 | CEFADROXIL | 217 | 0.1067 |
| 2 | ROPIVACAINE HYDROCHLORIDE | 141 | 0.0575 |
| 3 | AMINOPHYLLINE | 109 | 0.0541 |
| 4 | NEOMYCIN SULFATE | 96 | 0.0351 |
| 5 | NEOMYCIN OINTMENT | 59 | 0.0241 |
| 6 | THEOPHYLLINE ANHYDROUS | 254 | 0.0204 |
| 7 | ANTACID CALCIUM CARBONATE | 1 | 0.0189 |
| 8 | MOXIFLOXACIN HYDROCHLORIDE | 249 | 0.0120 |
| 9 | PYCNOGENOL 6X | 1 | 0.0116 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 477 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 427 |
| 2 | Anti-IgE [EPC] | 394 |
| 3 | Benzodiazepine [EPC] | 359 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 327 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 318 |
| 6 | Methylxanthine [EPC] | 264 |
| 7 | Calcium [EPC] | 256 |
| 8 | Provitamin D2 Compound [EPC] | 247 |
| 9 | Fluoroquinolone Antibacterial [EPC] | 215 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 247 | 0.0083 |
| 1 | Methylxanthine [EPC] | 264 | 0.0045 |
| 2 | Anti-IgE [EPC] | 394 | 0.0045 |
| 3 | Leukotriene Receptor Antagonist [EPC] | 102 | 0.0035 |
| 4 | Calcium [EPC] | 256 | 0.0017 |
| 5 | Fluoroquinolone Antibacterial [EPC] | 215 | 0.0017 |
| 6 | 5-Lipoxygenase Inhibitor [EPC] | 1 | 0.0015 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 318 | 0.0010 |
| 8 | Gadolinium-based Contrast Agent [EPC] | 4 | 0.0008 |
| 9 | Ergot Derivative [EPC] | 4 | 0.0008 |